First Alzheimer’s drug to slow disease progression gets full FDA approval, triggering broader Medicare coverage
By Meg Tirrell, Nadia Kounang and Tami Luhby, CNN (CNN) — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing disease. The Centers for Medicare and Medicaid Services said Thursday that it will now expand coverage of
Continue Reading